Skip to main content

Volume 18 Supplement 1

19th Annual SCMR Scientific Sessions

  • Poster presentation
  • Open access
  • Published:

Prognostic value of late gadolinium enhancement cardiac magnetic resonance in hypertrophic cardiomyopathy: a meta-analysis


Contrast-enhanced cardiovascular magnetic resonance (CMR) with late gadolinium enhancement (LGE) has emerged as an in vivo marker of myocardial fibrosis, although its significance in identifying high risk hypertrophic cardiomyopathy (HCM) patients remains unresolved. Previous meta-analyses have included studies with data involving overlapping patient populations, thus confounding effect estimates.


We searched PubMed and Web of Science for clinical trials that investigated the prognostic utility of LGE in HCM patients. We excluded studies with overlapping data. Pooled odds ratios (ORs), hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated to assess the role of LGE CMR in the risk stratification of HCM patients.


Five studies of unique cohorts were retrieved from 393 citations for the analysis. In total, 2993 patients (mean age = 54.6 years; median follow up = 36.8 months) were included. After synthesizing data, meta-analysis showed that the presence of LGE was associated with a significantly increased risk of sudden cardiac death (SCD)/aborted SCD (pooled OR = 3.42, 95%CI = 1.97-5.94; P < 0.001), cardiac death (pooled OR = 2.93, 95%CI = 1.53-5.61; P = 0.001), all-cause mortality (pooled OR=1.80, 95%CI = 1.21-2.69; P = 0.004), and a trend towards increased risk of heart failure death (pooled OR = 2.21, 95%CI = 0.84-5.80; P = 0.107). Three publications reported results with quantitative LGE. There was a significant relationship between the extent of LGE and risk of SCD (pooled HR 1.56/10% LGE, 95% CI = 1.33-1.82, p < 0.0001), all-cause mortality (pooled HR 1.29/10%LGE, 95% CI = 1.09-1.51, p = 0.002), heart failure mortality (pooled HR 1.61/10% LGE, 95% CI 1.21-2.13, p = 0.001), and cardiovascular mortality (pooled HR 1.57/10% LGE, 95% CI 1.30-1.89, p < 0.001). After adjusting for baseline characteristics, the extent of LGE remained a strong independent predictor for SCD events (pooled HRadjusted 1.36/10%LGE, 95% CI 1.10-1.69, p = 0.005).


Extensive LGE by CMR identifies high-risk HCM patients, and is an independent predictor of sudden death. Quantitative assessment of myocardial fibrosis by LGE can thus be a clinically useful tool to help risk stratify patients with HCM.

Figure 1
figure 1

Forest plot of presence of LGE and risk of adverse events.

Author information

Authors and Affiliations


Rights and permissions

Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit

The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Weng, Z., Chan, R.H., Yao, J. et al. Prognostic value of late gadolinium enhancement cardiac magnetic resonance in hypertrophic cardiomyopathy: a meta-analysis. J Cardiovasc Magn Reson 18 (Suppl 1), P117 (2016).

Download citation

  • Published:

  • DOI: